Doro Mind Raises $4.67M to Expand Digital Care Platform for Serious Mental Health Conditions
Doro Mind, a U.S.-based mental health care startup focused on providing structured support for individuals experiencing psychosis, schizophrenia, bipolar disorder, and related serious mental health conditions, has secured new venture funding to expand its care platform and scale its family-centered treatment model. The company offers a combination of clinical coordination, medication management support, and family coaching through its two core service lines, Doro Care and Doro Compass, aiming to improve continuity of care outside traditional hospital systems.
The startup’s most recent funding round took place in March 2026, when Doro Mind raised approximately $4.67 million in an Unattributed VC round. This investment represents the company’s largest disclosed financing event to date and marks a significant step in scaling its digital-first mental health care delivery system. The round brings Doro Mind’s total funding to roughly $7.44 million across multiple early-stage rounds, reflecting steady investor interest in technology-enabled behavioral health services.
According to startup financing data, the March 2026 round was led by SignalFire, a venture capital firm known for backing early-stage technology companies using data-driven investment strategies. SignalFire’s participation signals continued institutional confidence in Doro Mind’s approach to combining clinical care with scalable software infrastructure for mental health treatment. The firm has a history of investing in health technology platforms that aim to modernize care delivery through automation, analytics, and remote patient engagement tools.
In addition to SignalFire, Doro Mind’s broader investor base includes participation from Berkeley SkyDeck, the University of California, Berkeley’s startup accelerator. Berkeley SkyDeck is widely known for supporting early-stage startups through funding, mentorship, and access to academic and industry networks. Its involvement highlights the role of accelerator ecosystems in helping healthcare startups validate clinical workflows and refine early product-market fit before scaling commercially.
A third investor, City Light Capital, is also associated with Doro Mind’s funding history. City Light Capital is a mission-driven venture firm that invests in companies working across healthcare, education, and social impact sectors. Its participation aligns with Doro Mind’s focus on improving access to long-term, community-based mental health care for individuals and families navigating severe mental illness.
Doro Mind was founded in 2023 and is headquartered in Albany, New York. The company has grown rapidly in a short period, building a care model centered on “recovery-oriented” mental health support that emphasizes continuity, family involvement, and flexible access to clinicians. Its platform is designed to reduce gaps in care that often occur after hospitalization or during transitions between providers, particularly for patients with complex psychiatric conditions.
The company’s leadership team includes co-founders Mimi Liu and Brady Richards, both of whom bring prior experience from health technology organizations and have personal connections to mental health care through family experiences. Their combined background in healthcare operations and technology development has shaped Doro Mind’s product strategy, which integrates clinical workflows with digital tools aimed at improving adherence, communication, and long-term recovery outcomes.
With the new capital injection, Doro Mind is expected to expand its clinical team, enhance its digital care coordination platform, and broaden its geographic reach across U.S. states where demand for specialized psychiatric support continues to grow. The funding also positions the company to further develop its subscription-based care model, which blends ongoing clinical oversight with structured family engagement programs.
As mental health systems continue to face rising demand and workforce shortages, Doro Mind’s latest financing round underscores growing investor interest in scalable, hybrid care models that combine human clinical expertise with technology-enabled coordination.
